Cargando…
Erratum. Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes. Diabetes Care 2018;41:2361–2369
Autores principales: | Vaisar, Tomas, Durbin-Johnson, Blythe, Whitlock, Kathryn, Babenko, Ilona, Mehrotra, Rajnish, Rocke, David M., Afkarian, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609947/ https://www.ncbi.nlm.nih.gov/pubmed/30936112 http://dx.doi.org/10.2337/dc19-er06a |
Ejemplares similares
-
Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes
por: Vaisar, Tomas, et al.
Publicado: (2018) -
Erratum. The National Diabetes Education Program at 20 Years: Lessons Learned and Plans for the Future. Diabetes Care 2018;41:209–218
por: Siminerio, Linda M., et al.
Publicado: (2018) -
Erratum. Increased Prevalence of Type 2 Diabetes–Related Complications in Combined Type 2 Diabetes and Sickle Cell Trait. Diabetes Care 2018;41:2595—2602
por: Skinner, Sarah C., et al.
Publicado: (2019) -
Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41:1543–1556
por: van Baar, Michaël J.B., et al.
Publicado: (2019) -
Erratum. Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective. Diabetes Care 2018;41:1125–1131
por: Beran, David, et al.
Publicado: (2018)